Health
Potential inhibitors of SARS-CoV-2 identified – News-Medical.Net
Now, a new study published on the preprint server bioRxiv in August 2020 reports the discovery of two inhibitors of the helicase enzyme, which is essential for viral replication and the most highly conserved non-structural coronavirus (CoV) protein.
In the absence of an effective drug or vaccine, the fight against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent which causes COVID-19, has been slow and ineffectual. Now, a new study by researchers at the University of Texas and published on the preprint server bioRxiv* in August 2020 reports the discovery of two inhibitors of the helicase enzyme, which is essential for viral replication and the most highly conserved non-structural coronavirus (CoV) protein.
Atomic Str…
-
Noosa News6 hours agoHow Lily Steele-Park took her rapist to court and won
-
General20 hours ago‘Potential’ hacker contacts Qantas over data breach
-
Business11 hours agoFord CEO makes stunning prediction about artificial intelligence
-
Business21 hours ago5 amazing ASX ETFs for Aussie investors in July